Susan Berger, Ph.D.
About Susan Berger, Ph.D.
Susan Berger, Ph.D., is the U.S. Policy Lead at Bristol-Myers Squibb, with extensive experience in regulatory policy and strategy across multiple organizations.
Current Role at Bristol-Myers Squibb
Susan Berger is currently serving as the U.S. Policy Lead at Bristol-Myers Squibb, located in the Greater New York City Area. In this role, she represents the company on trade association groups and engages regulatory authorities at the policy level. Additionally, she leads a cross-divisional team that exchanges information about patient-centered drug development activities across regulatory and commercial landscapes. Susan also provides rigorous analyses to product teams, contributing to the development and education on regulatory policies that impact drug development and regulatory strategy.
Past Experience in Policy and Strategy
Before joining Bristol-Myers Squibb, Susan Berger accumulated a wealth of experience in policy and strategy roles. She worked as a Strategy and Policy Executive at Susan Berger Consulting from 2015 to 2016 in the Northeast Corridor. She was the Regulatory Policy Director at Amgen from 2013 to 2014 in the Washington D.C. Metro Area. Additionally, she served as a Consulting Fellow at SUNY Levin Institute from 2012 to 2013 in New York, and held multiple roles at Pfizer, including Worldwide Head, Safety & Regulatory Intelligence, and Chief of Staff to the Chief Medical Officer.
Career at Pfizer and Merck
Susan Berger's extensive career includes significant time at Pfizer, where she served in various capacities from 1999 to 2011. Her roles included Director of Science Policy, Senior Client Liaison, Chief of Staff to the Chief Medical Officer, and Worldwide Head of Safety & Regulatory Intelligence. Prior to her tenure at Pfizer, she was Associate Director of Corporate Licensing at Merck from 1997 to 1999. These positions involved substantial involvement in science policy, regulatory intelligence, and corporate licensing.
Educational Background
Susan Berger holds advanced degrees from prestigious institutions. She earned a Ph.D. in Physical Chemistry from Stanford University and an MBA with a focus on Strategy from Harvard Business School. Her educational foundation was laid at the University of Connecticut where she achieved a BS in Chemistry. This strong academic background has equipped her with the knowledge and skills necessary for her influential roles in the pharmaceutical and healthcare policy sectors.
Early Career and Industry Consulting
In the early stages of her career, Susan Berger held positions that laid the groundwork for her future roles in policy and strategy. She served as a Senior Industry Consultant at Dyn-Meridian from 1991 to 1995. Following this, she worked at the U.S. Department of Commerce as a Senior Chemical Policy Analyst for eight months in 1995 and served as a Science Fellow at the U.S. Department of State from 1990 to 1991. These roles provided her with a robust understanding of industry dynamics and regulatory frameworks.